100 related articles for article (PubMed ID: 2505713)
1. [Ambulatory registration of arterial pressure during treatment with perindopril. Effects on systolic pressure and hemodynamic implications].
Santoni JP; Asmar RG; Bizot-Espiard JG; Safar M
Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():51-6. PubMed ID: 2505713
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin converting enzyme inhibition decreases systolic blood pressure more than diastolic pressure as shown by ambulatory blood pressure monitoring.
Asmar RG; Pannier BM; Santoni JP; Safar ME
J Hypertens Suppl; 1988 Dec; 6(3):S79-81. PubMed ID: 3225692
[TBL] [Abstract][Full Text] [Related]
3. [24-hour effect and tolerance for perindopril (Prestarium) in mild and moderate essential hypertension].
Widimský J; Cihák R; Fedelesová V; Lefflerová K; Mayer O; Uhlír O
Vnitr Lek; 1992 Nov; 38(11):1066-71. PubMed ID: 1494869
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin converting enzyme inhibition, pulse wave velocity and ambulatory blood pressure measurements in essential hypertension.
Santoni JP; Asmar R; Safar ME
Clin Exp Hypertens A; 1989; 11 Suppl 2():535-44. PubMed ID: 2691127
[TBL] [Abstract][Full Text] [Related]
5. [24-hour effectiveness and tolerance of perindopril (Prestarium), an ACE inhibitor, in the treatment of mild to moderate hypertension. A 1-year Czech and Slovak study].
Widimský J; Fedelesová V; Uhlír O
Vnitr Lek; 1995 Jul; 41(7):441-4. PubMed ID: 7571476
[TBL] [Abstract][Full Text] [Related]
6. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
[TBL] [Abstract][Full Text] [Related]
7. [Cardiac hypertrophy and arterial compliance after antihypertensive treatment].
Asmar RG; Pannier BM; London GM; Safar ME
Arch Mal Coeur Vaiss; 1991 Dec; 84 Spec No 4():79-83. PubMed ID: 1838923
[TBL] [Abstract][Full Text] [Related]
8. [Blood pressure response to antihypertension treatment. Comparison of data obtained at the doctor's office and by ambulatory blood pressure measurement].
Herpin D; Degand B; Raynier P; Guyon C; Amiel A; Boutaud P; Demange J
Arch Mal Coeur Vaiss; 1989 Oct; 82(10):1733-7. PubMed ID: 2512875
[TBL] [Abstract][Full Text] [Related]
9. [The role of home pressure monitoring in the treatment hypertension in the practice of general medicine].
Widimský J; Balazovjech I; Lánská V
Vnitr Lek; 1999 Oct; 45(10):569-77. PubMed ID: 10951863
[TBL] [Abstract][Full Text] [Related]
10. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
[TBL] [Abstract][Full Text] [Related]
11. Effect of perindopril on 24-hour blood pressure levels and hemodynamic responses to physical and mental stress in elderly hypertensive patients.
Kuwajima I; Fujisawa A; Mitani K; Suzuki Y; Kuramoto K
Clin Ther; 1994; 16(6):962-71. PubMed ID: 7697693
[TBL] [Abstract][Full Text] [Related]
12. Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients--an Anglo-Scandinavian cardiac outcomes trial substudy.
Dolan E; Stanton AV; Thom S; Caulfield M; Atkins N; McInnes G; Collier D; Dicker P; O'Brien E;
J Hypertens; 2009 Apr; 27(4):876-85. PubMed ID: 19516185
[TBL] [Abstract][Full Text] [Related]
13. [Significance of inhibitors of conversion enzymes in elderly subjects. The example of perindopril].
Forette F; McClaran JM; Delesalle MC; Hervy MP; Bouchacourt P; Henry-Amar M; Santoni JP
Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():79-85. PubMed ID: 2505717
[TBL] [Abstract][Full Text] [Related]
14. Value of angiotensin converting enzyme inhibitors in the elderly: the example of perindopril.
Forette F; McClaran J; Delesalle MC; Hervy MP; Bouchacourt P; Henry-Amar M; Santoni JP
Clin Exp Hypertens A; 1989; 11 Suppl 2():587-603. PubMed ID: 2691131
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the dose-effect relationship of perindopril in the treatment of arterial hypertension].
Luccioni R; Frances Y; Gass R; Gilgenkrantz JM
Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():43-50. PubMed ID: 2505712
[TBL] [Abstract][Full Text] [Related]
16. Effects of perindopril on elastic and structural properties of large arteries in essential hypertension.
Lacourcière Y; Béliveau R; Conter HS; Burgess ED; Lepage S; Pesant Y; Spence JD; Asmar R; Carrière S; Plante GE;
Can J Cardiol; 2004 Jun; 20(8):795-9. PubMed ID: 15229761
[TBL] [Abstract][Full Text] [Related]
17. Development of blood pressure in spontaneously hypertensive rats after withdrawal of long-term treatment related to vascular structure.
Christensen KL; Jespersen LT; Mulvany MJ
J Hypertens; 1989 Feb; 7(2):83-90. PubMed ID: 2522478
[TBL] [Abstract][Full Text] [Related]
18. [Perindopril: first-line treatment of arterial hypertension].
Zanchetti A; Desche P
Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():63-72. PubMed ID: 2505715
[TBL] [Abstract][Full Text] [Related]
19. The correlation of office blood pressure and 24-hour ambulatory measurements in hypertensive patients - comparison between non-pharmacological treatment and antihypertensive medication.
Dzien A; Pfeiffer K; Dzien-Bischinger C; Hoppichler F; Lechleitner M
Eur J Med Res; 2000 Jun; 5(6):268-72. PubMed ID: 10882643
[TBL] [Abstract][Full Text] [Related]
20. Once daily perindopril versus slow release diltiazem in the treatment of mild to moderate essential hypertension. Canadian Study Group on Perindopril.
Can J Cardiol; 1994 Nov; 10 Suppl D():8D-12D. PubMed ID: 7954041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
